Sixty-Three Percent of Emerging Life Sciences Companies Outsource Government Pricing Capabilities to a Third-Party Vendor Rather than Implement a System In-House
Waltham, MA, June 8, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the launch of Government Pricing (GP) services within TGaS Advisors. The new services help pre-commercial and emerging life sciences companies develop their GP policies and methodologies and provide support for ongoing GP calculations. Because drug pricing in the U.S. remains at…
Read Now
Office Relocation in Gurgaon Creates Space for Growth and Innovation in the Asia-Pacific Region
Gurgaon, India, May 16, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the opening of its next-generation office space in Gurgaon, India. The opening of the new office is part of Trinity’s ongoing commitment to support development and innovation in the Asia-Pacific region.
Located near the “cyber hub of India,” the impressive new office boasts sleek contemporary design and state-of-the-art…
Read Now
Survey Reflects Trinity Employees Trust in Leadership and the Enthusiasm for Professional Growth and Opportunities
Waltham, MA, May 11, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has been named to Inc.’s annual Best Workplaces list. Featured in the May/June 2022 issue, hitting newsstands on May 17, 2022, and prominently featured on Inc.com, the list is the result of a comprehensive measurement of American companies that have excelled in creating exceptional workplaces and company culture.…
Read Now
New White Paper Entitled “Dawn of a New Era: Evolving Needs, Solutions and Technology in U.S. HEOR” Available from Trinity Life Sciences
Waltham, MA, May 10, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, explores the implications of significant evolution and growth in the U.S. Health Economics and Outcomes Research (HEOR) field over the last decade. Many changes have been driven by payers, regulators and clinicians who are increasingly looking to HEOR and Real-World Evidence…
Read Now
Seventy-Three Percent of Medical Affairs Leaders Rate the Overall Working Relationship with Commercial Leaders as Strong to Very Strong, According to a New TGaS Landscape Report from Trinity Life Sciences
Waltham, MA, April 25, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions released its latest TGaS Landscape report entitled, Commercial and Medical Affairs Leaders Landscape 2022. The report finds that in order to optimize the effectiveness between Commercial and Medical Affairs, a dynamic approach to…
Read Now
New White Paper Entitled “Diversity in Clinical Trials Participation: A Life Sciences Perspective” Available from Trinity Life Sciences
Waltham, MA, March 7, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions addresses the importance of diversity in clinical trials with support from its Diversity, Equity and Inclusion (DEI) committee in a new white paper entitled Diversity in Clinical Trials Participation: A Life Sciences Perspective. The paper highlights the striking disparity between U.S. clinical trial populations, the…
Read Now
Senior Partner Monica Martin De Bustamante to Head Up Function
Waltham, MA, March 1, 2022 — Trinity Life Sciences, a leader in global life sciences solutions, announced the significant expansion of its pricing and market access offerings. Leading the function, newly named Evidence, Value, Access & Pricing (EVAP), is Senior Partner Monica Martin De Bustamante. Ms. Martin De Bustamante had joined Trinity in October 2021 through the acquisition of CBPartners, a company she founded.
The expanded team is made up…
Read Now
Upcoming Webinar “CI Complexity in 2022 & Beyond: Making Friends with Volume and Velocity” on March 10 Explores Initial Findings from Qualitative Study
Waltham, MA, February 8, 2022 — Trinity Life Sciences, a leader in global life sciences solutions, conducted research to explore the importance and impact of Competitive Intelligence (CI) from the perspective of pharma clinical and commercial teams. A changing competitive environment and rapidly proliferating data streams have made relevant, actionable market intelligence critical for life science companies.…
Read Now
Suite of Integrated Solutions Developed by Dedicated Team Puts the Patient at the Center Across the Entire Product Development Lifecycle
Waltham, MA, February 2, 2022 – Trinity Life Sciences, a leader in global life sciences solutions, recognizes the vital importance of the Voice of the Patient across the entire product lifecycle. Trinity’s patient focus has evolved over 25 years, with the formation of the Patient Centricity Center of Excellence (COE) in 2019 to recognize the growing importance and involvement of…
Read Now
Waltham, MA, December 20, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know Now To Be Prepared For 2022” based on highlights it presented at the TGaS Advisors’ 2021 Fall Virtual Summit. The TGaS 2021 Fall Virtual Summit was held in November with over 450 attendees, the largest Summit to date.
As the commercial model continues to evolve, companies are capitalizing on opportunities to…
Read Now
